Company / EPS (Diluted)
MADRIGAL PHARMACEUTICALS, INC. EPS (Diluted) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$19.99
FY2025
5-year range
-$19.99 / -$5.45
FY2021-FY2025
Trend
-16.0%
vs FY2024
Sector context
#204 of 204
Health Care
What the data says
Among 204 Health Care companies, MADRIGAL PHARMACEUTICALS, INC. is in the bottom 0% for eps (diluted). Declined from $-14.63 to $-19.99 over the past 2 years.
Based on SEC 10-K filings.
-19.99 in FY2025.
Declined from $-14.63 to $-19.99 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 204This company -$19.99 Sector average -$0.89
▼
-2155.6% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 16.0% year-over-year.
- Ranks #204 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$19.99 | -16.0% |
| FY2024 | -$17.23 | -17.8% |
| FY2023 | -$14.63 | +15.1% |
| FY2022 | -$17.23 | -216.1% |
| FY2021 | -$5.45 | -145.5% |
| FY2020 | -$2.22 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026